334 related articles for article (PubMed ID: 33927352)
1. A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
Zadeh Shirazi A; McDonnell MD; Fornaciari E; Bagherian NS; Scheer KG; Samuel MS; Yaghoobi M; Ormsby RJ; Poonnoose S; Tumes DJ; Gomez GA
Br J Cancer; 2021 Aug; 125(3):337-350. PubMed ID: 33927352
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
[TBL] [Abstract][Full Text] [Related]
3. Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival.
Wan Y; Rahmat R; Price SJ
Acta Neurochir (Wien); 2020 Dec; 162(12):3067-3080. PubMed ID: 32662042
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
5. Upregulated functional gene expression programmes in tumour pericytes mark progression in patients with low-grade glioma.
Oudenaarden C; Sjölund J; Pietras K
Mol Oncol; 2022 Jan; 16(2):405-421. PubMed ID: 34018679
[TBL] [Abstract][Full Text] [Related]
6. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
[TBL] [Abstract][Full Text] [Related]
7. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
8. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
9. Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche.
Liu M; Ji Z; Jain V; Smith VL; Hocke E; Patel AP; McLendon RE; Ashley DM; Gregory SG; López GY
Acta Neuropathol Commun; 2024 Apr; 12(1):64. PubMed ID: 38650010
[TBL] [Abstract][Full Text] [Related]
10. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
12. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
13. Ventricular-Subventricular Zone Contact by Glioblastoma is Not Associated with Molecular Signatures in Bulk Tumor Data.
Mistry AM; Wooten DJ; Davis LT; Mobley BC; Quaranta V; Ihrie RA
Sci Rep; 2019 Feb; 9(1):1842. PubMed ID: 30755636
[TBL] [Abstract][Full Text] [Related]
14. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
15. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
Han L; Kamdar MR
Pac Symp Biocomput; 2018; 23():331-342. PubMed ID: 29218894
[TBL] [Abstract][Full Text] [Related]
16. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
17. DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.
Zadeh Shirazi A; Fornaciari E; Bagherian NS; Ebert LM; Koszyca B; Gomez GA
Med Biol Eng Comput; 2020 May; 58(5):1031-1045. PubMed ID: 32124225
[TBL] [Abstract][Full Text] [Related]
18. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
Lopes MB; Vinga S
BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
[TBL] [Abstract][Full Text] [Related]
19. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
Front Immunol; 2020; 11():1281. PubMed ID: 32765489
[No Abstract] [Full Text] [Related]
20. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Chaddad A; Desrosiers C; Hassan L; Tanougast C
Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
